another of my replies got cut short.
in the preveious msg i had said:
here's one thing he said that i think wasn't forthcoming enough:
The current price/earnings ratio at Pfizer stands at around 19, which is higher than its peers like GlaxoSmithKline (GSK), which trades at 13.5, and Eli Lilly (LLY) at 13.2.
what yahoo cut off was:
the author didn't mention that mrk's p/e was 20!!!!